List of Excipients in API meclofenamate sodium
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing meclofenamate sodium
Detailed excipient profiles for meclofenamate sodium
Excipient focus: CELLULOSE, MICROCRYSTALLINE
meclofenamate sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
meclofenamate sodium drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
meclofenamate sodium drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
meclofenamate sodium drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
meclofenamate sodium drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
meclofenamate sodium drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
meclofenamate sodium drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
meclofenamate sodium drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
meclofenamate sodium drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
meclofenamate sodium drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
meclofenamate sodium drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
meclofenamate sodium drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
meclofenamate sodium drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
meclofenamate sodium drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
meclofenamate sodium drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | meclofenamate sodium | 0378-2150 |
| >Company | >Ingredient | >NDC |
meclofenamate sodium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch